JFG
MDGL icon

Jefferies Financial Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Jefferies Financial Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$21.2K – 1730
2024
Q3 		$21.2K Buy
+100
New +$25.6K ﹤0.01% 1371
2023
Q1 		– Sell
-7,700
Closed -$2.23M – 1840
2022
Q4 		$2.23M Buy
+7,700
New +$753K 0.02% 620

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jefferies Financial Group's MDGL Position: Q2 2026 in Review

Jefferies Financial Group reduced its Madrigal Pharmaceuticals (MDGL) stake by 70% in Q2 2026, selling an estimated $751K and leaving 633 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #1349.

Jefferies Financial Group first reported a position in MDGL in Q1 2023 and has held it in 7 quarters since. The position peaked at $1.34M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Jefferies Financial Group held 633 shares of Madrigal Pharmaceuticals worth $340K as of Q2 2026.
  • Jefferies Financial Group sold 1,467 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $751K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1349 holding.
  • Jefferies Financial Group first reported a position in Madrigal Pharmaceuticals in Q1 2023 and has held it in 7 quarters since.
  • Jefferies Financial Group's Madrigal Pharmaceuticals position peaked at $1.34M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.